Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
2-phenyl-1-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-1,2,3,4-tetrahydro-isoquinolin-6-ol
- Development stage
- Unknown
- Lead developer
- Cassava Sciences
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule belonging to the class of 1-phenyltetrahydroisoquinolines. It features a phenyl group and a piperidine-containing ethoxy substituent on the isoquinoline core. The compound is listed as experimental and does not have an established clinical indication or approved use. Its mechanism of action has not been characterized in public databases or literature as of June 2025[1][7]. No information about its pharmacological activity or therapeutic target is available.
- Other names
- 2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol(1R)-2-phényl-1-{4-[2-(1-pipéridinyl)éthoxy]phényl}-1,2,3,4-tétrahydro-6-isoquinoléinol(1R)-2-phényl-1-{4-[2-(piperidin‑1‑yl)éthoxy]phényl}-3,4-dihydro‑1H‑isoquinolin‑6‑ol(see ChemSpider and DrugBank for additional IUPAC variants)[3][8]
Beyond the preview
Go deeper on 2-phenyl-1-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-1,2,3,4-tetrahydro-isoquinolin-6-ol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 2-phenyl-1-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-1,2,3,4-tetrahydro-isoquinolin-6-ol.